Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis
K. H. Vincent Lau(Boston University), Vaishali Sanchorawala(Boston Medical Center), John L. Berk(Boston University), Brian Spencer(Boston University), Michelle Kaku(Icahn School of Medicine at Mount Sinai), Luke Zheng(Boston University), Gheorghe Doros(Boston University), Tatiana Prokaeva(Boston University)
Cited by 4
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k